CLDN1 and ovarian cancer: It has been discovered that microRNA-155 (miR-155) targets claudin-1 with specificity and the increased expression of endogenous mature miR-155 may have an inhibitory effect on human ovarian cancer-initiating cell proliferation and invasion in vitro and in vivo through its effect on limiting claudin-1 expression.